Apollo, KKR seal €3bn Bayer reversible contraceptives deal; Aurelius agrees $323m Hain unit carve-out
Wednesday, September 16, 2026 · first reported by AltAssets
Apollo-managed funds and KKR completed €3bn (≈$3.3bn) co-investment in Bayer's long-acting reversible contraceptives business; Bayer retains majority stake and operational control.
- Firm
- Apollo
- Deal value
- $3.3B
- Asset class
- Private equity
- Geography
- Europe
The summary and fields above are extracted from the published reports and can contain errors. The linked articles are the source of record.
Coverage
1 sourceMore on Apollo
Everything on this firm →- Antin agrees sale of majority stake in Vicinity Energy to Harrison StreetPrivate Equity Wire +3
- CPP Investments sells A$4.5bn Australian toll road stakes to TransurbanIPE Real Assets
- Sycamore nears $9bn sale of Boots to Weston familyPrivate Equity Wire
- Eagle Point backs $450m US government-leased real estate recapitalisationIPE Real Assets
- CSC acquires 50% Watergardens mall stake from QIC for A$480mIPE Real Assets
- Lone Star buys €216m Dutch residential portfolio from Catella fundIPE Real Assets